[go: up one dir, main page]

AT346469B - Verfahren zur herstellung heterologer arterientransplantate - Google Patents

Verfahren zur herstellung heterologer arterientransplantate

Info

Publication number
AT346469B
AT346469B AT849875A AT849875A AT346469B AT 346469 B AT346469 B AT 346469B AT 849875 A AT849875 A AT 849875A AT 849875 A AT849875 A AT 849875A AT 346469 B AT346469 B AT 346469B
Authority
AT
Austria
Prior art keywords
heterological
producing
transplants
arterial
arterial transplants
Prior art date
Application number
AT849875A
Other languages
English (en)
Other versions
ATA849875A (de
Inventor
Heribert Dr Schmitz
Walter Dr Stoecklin
Original Assignee
Solco Basel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solco Basel Ag filed Critical Solco Basel Ag
Publication of ATA849875A publication Critical patent/ATA849875A/de
Application granted granted Critical
Publication of AT346469B publication Critical patent/AT346469B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625Vascular tissue, e.g. heart valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/062Apparatus for the production of blood vessels made from natural tissue or with layers of living cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/40Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915Method or apparatus for preparing biological material
    • Y10S623/916Blood vessel
    • Y10S623/917Collagen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT849875A 1974-11-11 1975-11-07 Verfahren zur herstellung heterologer arterientransplantate AT346469B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742453363 DE2453363B2 (de) 1974-11-11 1974-11-11 Verfahren zur herstellung heterologer arterientransplantate

Publications (2)

Publication Number Publication Date
ATA849875A ATA849875A (de) 1978-03-15
AT346469B true AT346469B (de) 1978-11-10

Family

ID=5930516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT849875A AT346469B (de) 1974-11-11 1975-11-07 Verfahren zur herstellung heterologer arterientransplantate

Country Status (26)

Country Link
US (1) US4083066A (de)
JP (1) JPS5516016B2 (de)
AR (1) AR207877A1 (de)
AT (1) AT346469B (de)
BE (1) BE835292A (de)
BR (1) BR7507404A (de)
CA (1) CA1076752A (de)
CH (1) CH595105A5 (de)
CS (1) CS193058B2 (de)
DD (1) DD121710A5 (de)
DE (1) DE2453363B2 (de)
DK (1) DK142044C (de)
EG (1) EG12503A (de)
ES (1) ES442354A1 (de)
FI (1) FI753040A (de)
FR (1) FR2290182A1 (de)
GB (1) GB1488534A (de)
HU (1) HU172194B (de)
IL (1) IL48395A (de)
IT (1) IT1052161B (de)
NL (1) NL7512007A (de)
PH (1) PH11934A (de)
PL (1) PL102824B1 (de)
SE (1) SE7512608L (de)
YU (1) YU276375A (de)
ZA (1) ZA757039B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5230097A (en) * 1975-09-02 1977-03-07 Kaneyasu Miyata Method of mounting different substitute blood vessel
JPS5675152A (en) * 1979-11-26 1981-06-22 Matsuda Ika Kogyo Reinforcing material for medical treatment
DE3166676D1 (en) * 1980-03-31 1984-11-22 Solco Basel Ag Method of making organic grafts
WO1982000091A1 (en) * 1980-07-01 1982-01-21 V Ketharanathan Vascular prostheses
US4911713A (en) * 1986-03-26 1990-03-27 Sauvage Lester R Method of making vascular prosthesis by perfusion
CH671683A5 (de) * 1987-03-05 1989-09-29 Sulzer Ag
CH675679A5 (de) * 1987-12-07 1990-10-31 Sulzer Ag
US5078735A (en) * 1990-06-18 1992-01-07 Mobin Uddin Kazi Prosthetic grafting method for bypass surgery
US5120833A (en) * 1991-03-15 1992-06-09 Alexander Kaplan Method of producing grafts
US5437287A (en) * 1992-08-17 1995-08-01 Carbomedics, Inc. Sterilization of tissue implants using iodine
CA2185447C (en) * 1994-03-14 2009-05-05 Steven Goldstein Treated tissue for implantation and preparation methods
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
AU2369695A (en) * 1994-04-29 1995-11-29 W.L. Gore & Associates, Inc. Improved blood contact surfaces employing natural subendothelial matrix and method for making and using the same
WO2000013612A1 (fr) * 1998-09-07 2000-03-16 Tapic International Co., Ltd. Vaisseau sanguin artificiel
US6432712B1 (en) * 1999-11-22 2002-08-13 Bioscience Consultants, Llc Transplantable recellularized and reendothelialized vascular tissue graft
EP1693025A1 (de) 2005-02-17 2006-08-23 Universität Zürich Verfahren zur Herstellung einer Prothese aus Gewebe
CN1903144A (zh) 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工韧带及其制备方法
CN1903143A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工血管及其制备方法
CN100482178C (zh) 2005-08-04 2009-04-29 广东冠昊生物科技有限公司 带生物膜的血管瘤夹
KR101376013B1 (ko) * 2005-08-26 2014-03-19 리전츠 오브 더 유니버스티 오브 미네소타 기관 및 조직의 세포제거 및 재세포화
CN1986001B (zh) * 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 生物护创膜
CN1986007B (zh) * 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 生物型外科补片
CN1986006A (zh) 2005-12-20 2007-06-27 广州知光生物科技有限公司 生物型神经导管
US20100023129A1 (en) * 2008-07-22 2010-01-28 Guo-Feng Xu Jawbone prosthesis and method of manufacture
CN101332314B (zh) * 2008-07-22 2012-11-14 广东冠昊生物科技股份有限公司 生物型关节软骨修补件
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
CN103458935B (zh) 2010-09-01 2016-08-03 明尼苏达大学董事会 使组织或器官再细胞化以提高其可移植性的方法
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
WO2014015274A1 (en) 2012-07-20 2014-01-23 The General Hospital Corporation Methods for tissue passivation
US10292381B2 (en) 2012-07-20 2019-05-21 The General Hospital Corporation Vessel treatment systems, methods, and kits
CA2907161A1 (en) 2013-03-15 2014-09-25 Miromatrix Medical Inc. Use of perfusion decellularized liver for islet cell recellularization
AU2014290513B2 (en) * 2013-07-18 2017-07-27 The General Hospital Corporation Vessel treatment systems, methods, and kits
EP3509651B1 (de) 2016-09-06 2022-12-28 Miromatrix Medical Inc. Verwendung von reseziertem leberserum zum engineering der ganzen leber

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1628966A (en) * 1919-09-16 1927-05-17 Glasel Charles John Tanning apparatus
US1724954A (en) * 1921-05-20 1929-08-20 United Shoe Machinery Corp Method for treating hides and skins
US2900644A (en) * 1955-11-01 1959-08-25 Johnson & Johnson Heterograft material
US3093439A (en) * 1961-07-05 1963-06-11 Johnson & Johnson Process for preparing tanned collagenous material with dialdehyde starch
US3093440A (en) * 1961-07-05 1963-06-11 Johnson & Johnson Process for preparing collagenous material tanned with polyacrolein
US3966401A (en) * 1974-07-01 1976-06-29 Hancock Laboratories Incorporated Preparing natural tissue for implantation so as to provide improved flexibility

Also Published As

Publication number Publication date
ATA849875A (de) 1978-03-15
BR7507404A (pt) 1976-08-03
DD121710A5 (de) 1976-08-20
PL102824B1 (pl) 1979-04-30
HU172194B (hu) 1978-06-28
CH595105A5 (de) 1978-01-31
PH11934A (en) 1978-09-15
BE835292A (fr) 1976-03-01
JPS5516016B2 (de) 1980-04-28
DK142044B (da) 1980-08-18
IL48395A0 (en) 1975-12-31
EG12503A (en) 1979-03-31
CS193058B2 (en) 1979-09-17
FR2290182B1 (de) 1979-05-04
DE2453363A1 (de) 1976-05-13
GB1488534A (en) 1977-10-12
DK142044C (da) 1981-01-12
CA1076752A (en) 1980-05-06
YU276375A (en) 1982-06-30
IT1052161B (it) 1981-06-20
US4083066A (en) 1978-04-11
NL7512007A (nl) 1976-05-13
AR207877A1 (es) 1976-11-08
DK504575A (da) 1976-05-12
FR2290182A1 (fr) 1976-06-04
JPS5179998A (de) 1976-07-12
IL48395A (en) 1978-03-10
FI753040A (de) 1976-05-12
SE7512608L (sv) 1976-05-12
ZA757039B (en) 1976-11-24
ES442354A1 (es) 1977-04-01
DE2453363B2 (de) 1976-08-26

Similar Documents

Publication Publication Date Title
AT346469B (de) Verfahren zur herstellung heterologer arterientransplantate
AT341098B (de) Verfahren zur herstellung von stabilem blutplasma
AT335995B (de) Verfahren zur herstellung von ketoisophoron
AT370714B (de) Verfahren zur herstellung von aldehyden
AT338232B (de) Verfahren zur herstellung von ketoisophoron
AT356668B (de) Verfahren zur herstellung von imidazolyl- guanidinen
AT342015B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
DD122963A5 (de) Verfahren zur herstellung fluorierter verbindungen
AT343109B (de) Verfahren zur herstellung von indoleninderivaten
AT345449B (de) Verfahren zur herstellung von influenzavirus-bestandteilen
AT344136B (de) Verfahren zur herstellung von neuem 2-deutero-3-fluor-dl-alanin
ATA425375A (de) Verfahren zur herstellung von prostaglandinartigen (d1)-verbindungen
AT344915B (de) Verfahren zur herstellung von tabletten
AT340546B (de) Verfahren zur herstellung von sauremassen
AT355725B (de) Verfahren zur herstellung stabiler loesungen
DD130933A5 (de) Verfahren zur herstellung von sulfinylazetidinonen
AT351523B (de) Verfahren zur herstellung von 2-alkyl-5- nitroimidazolderivaten
AT338253B (de) Verfahren zur herstellung von diamiden
AT343131B (de) Verfahren zur herstellung von poly- (n-alkyliminoalanen)
AT340885B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
AT387375B (de) Kontinuierliches verfahren zur herstellung von chlordioxid
AT342063B (de) Verfahren zur herstellung von 1-phenyl-4-amino-5-chlor-pyridazon (6)
AT340589B (de) Verfahren zur herstellung von delta3-cephalosporinestern
AT337150B (de) Verfahren zur herstellung von d-penicillamin
ATA625774A (de) Verfahren zur herstellung von phenylpyridazonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee